These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 22328825

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma.
    Kandalam MM, Beta M, Maheswari UK, Swaminathan S, Krishnakumar S.
    Mol Vis; 2012; 18():2279-87. PubMed ID: 22969266
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma.
    Salnikov AV, Groth A, Apel A, Kallifatidis G, Beckermann BM, Khamidjanov A, Ryschich E, Büchler MW, Herr I, Moldenhauer G.
    J Cell Mol Med; 2009 Sep; 13(9B):4023-33. PubMed ID: 20196789
    [Abstract] [Full Text] [Related]

  • 6. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
    Subramanian N, Kanwar JR, Kanwar RK, Sreemanthula J, Biswas J, Khetan V, Krishnakumar S.
    PLoS One; 2015 Sep; 10(7):e0132407. PubMed ID: 26176230
    [Abstract] [Full Text] [Related]

  • 7. Topotecan-induced ABCG2 expression in MCF-7 cells is associated with decreased CD24 and EpCAM expression and a loss of tumorigenicity.
    Huber S, Wege AK, Bernhardt G, Buschauer A, Brockhoff G.
    Cytometry A; 2015 Aug; 87(8):707-16. PubMed ID: 25892097
    [Abstract] [Full Text] [Related]

  • 8. EpCAM expression in retinoblastoma: a novel molecular target for therapy.
    Krishnakumar S, Mohan A, Mallikarjuna K, Venkatesan N, Biswas J, Shanmugam MP, Ren-Heidenreich L.
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4247-50. PubMed ID: 15557427
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
    Sicchieri RD, da Silveira WA, Mandarano LR, de Oliveira TM, Carrara HH, Muglia VF, de Andrade JM, Tiezzi DG.
    Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo.
    English DP, Bellone S, Schwab CL, Roque DM, Lopez S, Bortolomai I, Cocco E, Bonazzoli E, Chatterjee S, Ratner E, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Santin AD.
    Cancer; 2015 Feb 01; 121(3):403-12. PubMed ID: 25251053
    [Abstract] [Full Text] [Related]

  • 15. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
    Mitra M, Misra R, Harilal A, Sahoo SK, Krishnakumar S.
    Mol Vis; 2011 Feb 01; 17():2724-37. PubMed ID: 22065926
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro.
    Bellone S, Black J, English DP, Schwab CL, Lopez S, Cocco E, Bonazzoli E, Predolini F, Ferrari F, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD.
    Am J Obstet Gynecol; 2016 Jan 01; 214(1):99.e1-8. PubMed ID: 26272866
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
    Karimi-Busheri F, Zadorozhny V, Li T, Lin H, Shawler DL, Fakhrai H.
    J Stem Cells; 2011 Jan 01; 6(1):9-20. PubMed ID: 22997842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.